Pityriasis rosea‐like eruptions following vaccination with BNT162b2 mRNA COVID‐19 Vaccine
Benoit M. Cyrenne +3 more
openalex +1 more source
Pityriasis rosea-like drug eruption secondary to deucravacitinib. [PDF]
Punchihewa N, Lee S, Tan CG, Foley P.
europepmc +1 more source
Pityriasis rosea, COVID‐19 and vaccination: new keys to understand an old acquaintance
José Manuel Busto‐Leis +7 more
openalex +1 more source
Herald Patch as the Only Evidence of Pityriasis Rosea: Clinical, Laboratory and Pathogenetic Features. [PDF]
Drago F +5 more
europepmc +1 more source
Infectueuze pathologie in de kinderdermatologie [PDF]
Batteauw, Anneleen +2 more
core +1 more source
A retrospective analysis of medications associated with pityriasis rosea reported in the FDA adverse events reporting system. [PDF]
Mashoudy KD, Ye-Tay J, Nouri K.
europepmc +1 more source
Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature. [PDF]
Veraldi S +3 more
europepmc +1 more source
Atypical Pityriasis rosea in a black child: a case report [PDF]
A Amer +12 more
core +2 more sources

